Antibiotice S.A. (BVB:ATB)

Market Cap	1.43B -12.7%
Revenue (ttm)	638.98M -4.1%
Net Income	31.69M -67.5%
EPS	0.05 -67.5%
Shares Out	671.34M
PE Ratio	45.02
Forward PE	n/a
Dividend	0.04 (1.69%)
Ex-Dividend Date	Oct 1, 2026

Volume	130,975
Open	2.115
Previous Close	2.115
Day's Range	2.070 - 2.130
52-Week Range	1.752 - 2.725
Beta	0.25
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 17, 2026

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company provides generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,356
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2025, Antibiotice's revenue was 660.04 million, a decrease of -4.16% compared to the previous year's 688.70 million. Earnings were 51.77 million, a decrease of -49.35%.

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Jun 30, 2026

Data Sources Report a data error